QA: Eton Pharmaceuticals Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001710340_2026_Eton_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001710340, Eton Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 60,581,000
1 IntangibleAssetsNetIncludingGoodwill 30,878,000
2 PropertyPlantAndEquipmentNet 326,000
3 remainder_Assets 329,000
4 LiabilitiesCurrent 38,490,000
5 LiabilitiesNoncurrent 27,470,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 145,003,369
8 SellingGeneralAndAdministrativeExpense 85,388,366
9 ResearchAndDevelopmentExpense 8,476,616
10 remainder_Expenses 32,612
11 remainder_Revenues 122,325,712
12 remainder_NetIncome -4,468,814
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 92,114,000
1 Liabilities 65,960,000
2 Expenses 238,900,963
3 Revenues 122,325,712
4 StockholdersEquity 26,154,000
5 NetIncome -121,044,065
6 ComprehensiveNetIncome -121,044,065
7 BaseVar 261,884,744
8 EconomicCapitalRatiobeforeLimitedLiability -0.810
9 EconomicCapitalRatio 1.34

Edgar->Model Mapping

Feature Distribution

Change over Time